Overview

Abatacept in ANCA Associated Vasculitis

Status:
Terminated

Trial end date:
2008-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate whether abatacept can prevent relapse in patients with ANCA associated vasculitis(AAV). This is a randomised double blinded placebo controlled trial.

Phase:

Phase 2

Details

Lead Sponsor:

Imperial College London

Collaborator:

Bristol-Myers Squibb

Treatments:

Abatacept